InfraReDx declared that it will display the LipiScan IVUS Coronary Imaging System at the American College of Cardiology 60th Annual Scientific Session and Innovation in Intervention 2011.
The event is to be held at the Ernest N. Morial Convention Center, New Orleans from April 2-5, 2011.
The LipiScan IVUS Coronary Imaging System uses the grayscale intravascular ultrasound (IVUS) and the company’s in-house near infrared spectroscopy lipid core plaque detection technology to allow the detection of the lipid-core plaques.
InfraReDx president and chief executive officer, Donald Southard, stated that the data obtained from the IVUS can help to establish the degree of stenosis and for monitoring stenting. He mentioned that the LipiScan data proves useful in identifying stenotic lipid core plaques that can cause peri-stenting myocardial infarction on dilation. He also added that the chemistry and structure of coronary plaques can be determined by doctors in a single pullback with the help of the LipiScan IVUS.
InfraReDx founder, chairman and chief medical officer, James E. Muller, will deliver a presentation on the topic, “Multimodality Near-infrared Spectroscopy and IVUS Coronary Imaging: Strategies to Prevent the First Coronary Event and Improve Coronary Stenting,” at the Cardiovascular Innovations Forum on April 3, 2011.